Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30572

1.

Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.

Arigami T, Uchikado Y, Omoto I, Sasaki K, Kita Y, Owaki T, Yanagita S, Mori S, Kurahara H, Okumura H, Maemura K, Natsugoe S.

Anticancer Res. 2018 Sep;38(9):5447-5452. doi: 10.21873/anticanres.12876.

PMID:
30194201
2.

Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.

Hayata K, Ojima T, Nakamori M, Nakamura M, Katsuda M, Kitadani J, Takeuchi A, Tabata H, Maruoka S, Yamaue H.

Anticancer Res. 2018 Sep;38(9):5267-5273. doi: 10.21873/anticanres.12852.

PMID:
30194177
3.

Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.

Furukawa T, Hamai Y, Hihara J, Emi M, Yamakita I, Ibuki Y, Kurokawa T, Okada M.

Anticancer Res. 2018 Sep;38(9):5239-5245. doi: 10.21873/anticanres.12848.

PMID:
30194173
4.

The white substance may be a potential endoscopic marker for flat esophageal mucosal neoplastic lesions: A new endoscopic observation.

Yang G, Du W, Zhang X, Huang T, Zhang J, Liu J, Ling Y.

Medicine (Baltimore). 2018 Aug;97(35):e11885. doi: 10.1097/MD.0000000000011885.

5.

RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.

Lu H, Jiang T, Ren K, Li ZL, Ren J, Wu G, Han X.

Cell Physiol Biochem. 2018;49(1):217-225. doi: 10.1159/000492872. Epub 2018 Aug 23.

6.

Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling.

Xu WW, Zheng CC, Huang YN, Chen WY, Yang QS, Ren JY, Wang YM, He QY, Liao HX, Li B.

J Agric Food Chem. 2018 Sep 5;66(35):9248-9258. doi: 10.1021/acs.jafc.8b04020. Epub 2018 Aug 27.

PMID:
30113849
7.

Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.

Li Y, Sui H, Jiang C, Li S, Han Y, Huang P, Du X, Du J, Bai Y.

Cell Physiol Biochem. 2018;48(5):2035-2045. doi: 10.1159/000492541. Epub 2018 Aug 10.

8.

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.

Peng H, Yao S, Dong Q, Zhang Y, Gong W, Jia Z, Yan L.

Medicine (Baltimore). 2018 Aug;97(31):e11697. doi: 10.1097/MD.0000000000011697.

9.

SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.

Lin J, Yang T, Peng Z, Xiao H, Jiang N, Zhang L, Ca D, Wu P, Pan Q.

Cell Physiol Biochem. 2018;48(1):397. doi: 10.1159/000491769. Epub 2018 Aug 2.

10.

MiR-543 Promotes Migration, Invasion and Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Targeting Phospholipase A2 Group IVA.

Zhao H, Diao C, Wang X, Xie Y, Liu Y, Gao X, Han J, Li S.

Cell Physiol Biochem. 2018;48(4):1595-1604. doi: 10.1159/000492281. Epub 2018 Aug 2.

11.

Should aspirin and PPIs be recommended for patients with Barrett's oesophagus?

Hvid-Jensen F, Drewes AM.

Lancet. 2018 Aug 4;392(10145):362-364. doi: 10.1016/S0140-6736(18)31618-0. Epub 2018 Jul 26. No abstract available.

12.

Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature.

Yu W, Guo Y.

Medicine (Baltimore). 2018 Jul;97(30):e11614. doi: 10.1097/MD.0000000000011614. Review.

13.

Successful outcome after radiotherapy in esophageal squamous cell carcinoma with choroidal metastasis: A case report and review of literature.

Hsiao YT, Li SH, Wang YM, Kuo HK.

Indian J Ophthalmol. 2018 Aug;66(8):1215-1217. doi: 10.4103/ijo.IJO_259_18. Review.

14.

Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma.

Yang XZ, He QJ, Cheng TT, Chi J, Lei ZY, Tang Z, Liao QX, Zhang H, Zeng LS, Cui SZ.

Cell Physiol Biochem. 2018;48(1):251-262. doi: 10.1159/000491724. Epub 2018 Jul 13.

15.
16.

Impact of high body mass index on surgical outcomes and long-term survival among patients undergoing esophagectomy: A meta-analysis.

Gao H, Feng HM, Li B, Lin JP, Yang JB, Zhu DJ, Jing T.

Medicine (Baltimore). 2018 Jul;97(28):e11091. doi: 10.1097/MD.0000000000011091.

17.

Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.

Plum PS, Ulase D, Bollschweiler E, Chon SH, Berlth F, Zander T, Alakus H, Hölscher AH, Bruns CJ, Schallenberg S, Quaas A, Loeser H.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1731-1739. doi: 10.1007/s00432-018-2698-1. Epub 2018 Jul 4.

PMID:
29974234
18.

Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study.

Markoš P, Brčić I, Brčić L, Jakić-Razumović J, Pulanić R.

Croat Med J. 2018 Jun 30;59(3):100-107.

19.

CD117 Expression in Squamous Cell Carcinoma of the Oesophagus.

Moreira LF, Maino MM, Garbin HI, DA Natividade GR, Volkweis BS, Kulczynski JU.

Anticancer Res. 2018 Jul;38(7):3929-3933. doi: 10.21873/anticanres.12678.

PMID:
29970514
20.

Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.

Hong D, Liu T, Huang W, Liao Y, Wang L, Zhang Z, Chen H, Zhang X, Xiang Q.

Cell Physiol Biochem. 2018;47(5):1785-1799. doi: 10.1159/000491060. Epub 2018 Jun 28.

Supplemental Content

Loading ...
Support Center